Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Actinogen Medical ( (AU:ACW) ) has issued an announcement.
Actinogen Medical Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, demonstrating a commitment to transparency and accountability. This release is significant for stakeholders as it confirms the company’s compliance with governance standards, potentially enhancing investor confidence and supporting its market position.
More about Actinogen Medical
Actinogen Medical Limited operates in the biotechnology industry, focusing on the development of innovative therapies for neurological and neurodegenerative diseases. The company is committed to advancing treatments that address significant unmet medical needs in these areas.
YTD Price Performance: 20.0%
Average Trading Volume: 3,778,263
Technical Sentiment Signal: Hold
Current Market Cap: A$95.31M
See more data about ACW stock on TipRanks’ Stock Analysis page.